溶解性 | DMSO 10 mg/mL Water <1 mg/mL Ethanol 30 mg/mL |
存贮条件 | 储存温度-20°C |
备注 | GSK461364 inhibits purified Plk1 with Ki of 2.2 nM. It is more than 1000-fold selective against Plk2/3. Phase 1. |
生化机理 | GSK-461364A is a potent small molecule Polo-like kinase 1 (PLK1) inhibitor with a Ki of 2.2 nM. GSK-461364A is an ATP-competitive inhibitor of Plk1 and forms a rapidly reversible complex with Plk1. |
别名 | 5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-((R)-1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide;5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-((R)-1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide |
GSK461364
GSK461364 (订货以英文为准)
编号:G127124
CAS号:929095-18-1
分子式:C27H28F3N5O2S
分子量:543.62
产品名称 | GSK461364 |
中文名称 | GSK461364 |
CAS号 | 929095-18-1 |
分子式(M.F.) | C27H28F3N5O2S |
分子量(M.W.) | 543.62 |
储存条件 | -20°C储存;充氩 |
搜索质检报告(COA)
搜索MSDS
相关产品